Gästeforum » AG, Huvepharma AD, Our

What is the Atkins diet and how can it help you?

When Dr Robert Atkins first published his book Columbus Blue Jackets Jerseys For Sale ,"Dr Atkins Diet Revolution", in 1972 the broad medical and nutritional community dismissed it as just another quack diet plan.

Thirty years later, Dr Atkins nutritional theories have found wide spread support in scientific research circles, while creating a legion of followers who have adopted low-carb eating as a way of life.

Today, the Atkins brand of low-carb foods outsells all other brands in the category in the US and the UK. In the US some 10% of the population is on some form of the Atkins diet.

Although it is hard to believe, 47% of Women and 63% of Men are either overweight or obese.

Obesity has a huge impact on the economy and the overall health of the population.

The diet was designed to work safely and affectively with your body and Dr Atkins best selling book on the subject provides the first steps to understanding the diet.

With the Atkin Diet, you can stop counting calories Cheap Columbus Blue Jackets Jerseys , stop weighing food portions, and stop feeling as though you are deprived from eating good-tasting and satisfying food!

Best of all, you will see amazing results in a short amount of time. Your body will be thinner, the number on the scales will go down, and all those overwhelming food cravings will be gone! Just imagine losing weight while still enjoying many of your favorite foods.

invites you to learn more about how the Atkins Diet plan works! Global Animal Health Active Pharmaceutical Ingredients Market Poised to Rake rea
Posted by harshadac on August 1st, 2017


The global animal health active pharmaceutical ingredient (API) market is projected to register an impressive expansion at 7.3% CAGR during the forecast period 2017 to 2025, according to a recent study by Persistence Market Research (PMR). PMR’s study estimates the market to increase from revenues worth US$ 5 Josh Anderson Blue Jackets Jersey ,216.1 Mn in 2017 to reach US$ 9,162.2 Mn by 2025-end.


Limited Insurance or Government Intervention Provides Smooth Flow to the Market Growth in APAC


Asia Pacific (APAC) will continue to be the most lucrative region in the global animal health active pharmaceutical ingredient market, with sales exhibiting the second highest CAGR through 2025. APAC has remained one of the largest API suppliers, at affordable costs. Governments across APAC have been making investments and focusing on local manufacturing facilities of APIs. Favorable policies offered by these governments have been shifting the focus of API manufacturers in moving their production bases to APAC countries, such as India and China. In addition, limited insurance or government intervention provides smooth flow to market growth in these regions.


Download Report Table of Content, Figures Nick Foligno Blue Jackets Jersey , and Tables @ align="JUSTIFY">However, animal health API products manufactured in APAC countries do not meet regulatory standards, and there has been increasing concerns pertaining to the quality of APIs, especially those produced in China and India. Western regulatory bodies are becoming stricter in the inspection of APIs produced in these regions. Manufacturers are further facing challenges in bridging the gap between the cost and quality of APIs. These factors will inhibit growth of the market in APAC.


Europe to Remain the Second Largest Market for Animal Health APIs


Europe will remain the second largest market for animal health active pharmaceutical ingredients. Leading healthcare companies are located in the Europe, which in turn has boosted requirement for veterinary APIs in the region. Consumption of veterinary drugs in Europe has surged substantially over the past few years. Spain has been witnessed to be the largest consumer of veterinary antimicrobial APIs in the EU. In addition, rising improvements in the animal productivity has driven growth of the animal health industry in this region. These incidences are expected to augment growth of the animal health API market in Europe.


A sample of this report is available upon request @ align="JUSTIFY">However, the pharmaceutical industry in Europe has been concerned with potential short-term impacts of REACH regulations. This is likely to result in decreased supply of materials David Savard Blue Jackets Jersey , or reagents, which are not preregistered by EU suppliers. In addition, dynamic changes in Europe’s macro-economic environment, such as the Brexit, has been impacting the intra-European trade and overall pharmaceutical sector. These factors might curb growth of the animal health API market in Europe.


Antiparasitics to Remain the Largest Adopted APIs in the Market


Antiparasitics will continue to be the largest adopted API in the market, followed by anti-infectives. Sales of Antiparasitics are expected to register the fastest expansion, to account for the largest revenues by 2025-end. In contrast Oliver Bjorkstrand Blue Jackets Jersey , revenues from sales of anesthetics and NSAIDs will remain comparatively lower than antiparasitics and anti-infectives.


Key market players profiled in PMR’s report include Glenmark Pharmaceutical Limited., Zoetis, Inc., Eli Lilly & Co., Sanofi Winthrop Industrie (CEPiA), Indukern, S.A. Ryan Murray Blue Jackets Jersey , Ofichem BV, P&R S.p.A (Olon S.p.A), Lonza Group AG, Huvepharma AD, Ourofino Saude Animal, Blanver Farmoquimica E Farmaceutica S.A., Zhejiang Hisun Pharmaceutical Co. Sonny Milano Blue Jackets Jersey , Ltd, Changzhou Yabang-Qh Pharmachem Co., Ltd., Shanghai Pharmtech Co., Ltd., Ningxia Tairui Pharmaceutical Co., Ltd. Cam Atkinson Blue Jackets Jersey , Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Sequent Scientific Ltd., NGL Fine-Chem Ltd., Omkar Speciality Chemicals Ltd., Excel Industries Ltd.